Pharmaceuticals, Biotechnology and Life Sciences
Menarini Ricerche’s study showed that a transmembrane glycoprotein, is robustly expressed in a number of solid tumours, liek pancreatic and…
Roche study showed entrectinib shrank tumours (objective response rate; ORR) in all children and adolescents who had NTRK, ROS1 or ALK fusion-positive solid tumours (11 of 11 patients), including two patients achieving a complete response.
The National Institute for Health and Care Excellence (NICE) has recommended the use of the EUSA Pharma’s targeted cancer immunotherapy, QARZIBA…